drugset / Trial / NCT00395343
Sitagliptin Added-on to Insulin Study (0431-051)
RandomizedParallel-groupDouble-blindTreatment
Summary
A clinical study to determine the safety and efficacy of sitagliptin in patients with Type 2 Diabetes Mellitus who have inadequate glycemic control on insulin or insulin/metformin combination therapy.
Timeline
- Start
- 2006-12-11
- Primary completion
- 2008-10-13
- Completion
- 2008-10-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sitagliptin | Small molecule | 100 mg | — |